tumor sequencing
The partners hope to expand the Alabama Cancer Care program after pilot data showed point-of-care expert reviews of genomic test results influence patient care.
Neoantigen Detection Platform Picks up T-Cell Responses to Tumor Mutations
Researchers combined tumor sequence, transcriptome, and patient immune cell response clues in their tumor-specific neoantigen detection and validation platform.
Germany to Test Genomics-Based Precision Medicine for Cancer, Rare Disease in National Pilot Project
Premium
With reimbursement from public health insurance, the "model project" will run for at least five years and examine the utility of genomic sequencing for advanced cancer and rare disease patients.
BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects
The partners plan to analyze patients' tumors, immune systems, and tumor microenvironments to predict treatment response and identify targetable molecular alterations.
Myriad Genetics, Intermountain Precision Genomics Obtain NY Certification for Solid Tumor Testing
The NYS certification enables the companies to offer solid tumor testing through the Precise Oncology Solutions suite in all 50 states.